Skip to main content
Normal View

Clinical Indemnity.

Dáil Éireann Debate, Wednesday - 9 July 2008

Wednesday, 9 July 2008

Questions (84, 85)

Thomas P. Broughan

Question:

110 Deputy Thomas P. Broughan asked the Minister for Finance if he has received a report from the State Claims Agency and the National Treasury Management Agency regarding the expected volume and estimates of possible costs of claims for patients who contracted MRSA in hospitals here; if the clinical indemnity scheme is the mechanism by which MRSA claims will be discharged; and if he will make a statement on the matter. [28050/08]

View answer

Written answers

I am informed by the State Claims Agency that to date 100 claims have been received relating to MRSA. Liability in those cases is still to be decided. Until the question of legal liability is settled, it is not possible to indicate what role, if any, the clinical indemnity scheme will play. In the circumstances, it is also not possible to estimate the number of cases, or the costs, that might arise in the future.

Thomas P. Broughan

Question:

111 Deputy Thomas P. Broughan asked the Minister for Finance if he has contacted and received a report from the State Claims Agency and National Treasury Management Agency regarding possible claims by persons whose homes have been damaged by defective pyrite infill and following the failure of national and local government to implement the building regulations before September 2007; if his attention has been drawn to the fact that such claims might constitute the costliest of class and individual actions ever taken against the State; and if he will make a statement on the matter. [28051/08]

View answer

I am informed by the State Claims Agency that it has not received any claims from people whose homes have been allegedly damaged by defective pyrite infill. Claims of defects in homes are a matter between the home buyer, the builder and the builder's insurer.

Top
Share